FDA Shuts Down Manufacturer of Autism ‘Drugs’ The U.S. Food and Drug Administration (FDA) has shut down operations of Louisiana-based Pick and Pay Inc./Cili Minerals, a manufacturer of drugs and dietary supplements, after finding it was falsely marketing products as being able to treat autism and other conditions. A U.S. district judge issued the order after the ... News in Brief
Free
News in Brief  |   May 01, 2017
FDA Shuts Down Manufacturer of Autism ‘Drugs’
Author Notes
Article Information
Special Populations / Autism Spectrum / Regulatory, Legislative & Advocacy / News in Brief
News in Brief   |   May 01, 2017
FDA Shuts Down Manufacturer of Autism ‘Drugs’
The ASHA Leader, May 2017, Vol. 22, 8. doi:10.1044/leader.NIB2.22052017.8
The ASHA Leader, May 2017, Vol. 22, 8. doi:10.1044/leader.NIB2.22052017.8
The U.S. Food and Drug Administration (FDA) has shut down operations of Louisiana-based Pick and Pay Inc./Cili Minerals, a manufacturer of drugs and dietary supplements, after finding it was falsely marketing products as being able to treat autism and other conditions.
A U.S. district judge issued the order after the FDA found that the company improperly manufactured and distributed drugs and dietary supplements and claimed products could treat everything from autism to epilepsy, brain injury, bipolar disorder and cancer—despite having no FDA approval for any drugs for any use. The company’s website, for example, claimed that PoLith and Lithium could address autism.
0 Comments
Submit a Comment
Submit A Comment
Name
Comment Title
Comment


This feature is available to Subscribers Only
Sign In or Create an Account ×
FROM THIS ISSUE
May 2017
Volume 22, Issue 5